TALPHERA, INC. Restructuring and Related Cost, Number of Positions Eliminated
TALPHERA, INC. (TLPH) had Restructuring and Related Cost, Number of Positions Eliminated of 3000.00% as of 2020-03-16, per its 10-K filed 2022-03-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated · last filed 2022-03-10
- TALPHERA, INC. restructuring and related cost, number of positions eliminated for the quarter ending 2015-03-31 was 1900.00%.
| Period end | Restructuring and Related Cost, Number of Positions Eliminated | Restructuring and Related Cost, Number of Positions Eliminated 3 month | Restructuring and Related Cost, Number of Positions Eliminated 9 month |
|---|---|---|---|
| 2020-03-16 | 3000.00% 10-K · filed 2022-03-10 | ||
| 2015-09-30 | 1900.00% 10-Q · filed 2015-11-03 | ||
| 2015-03-31 | 1900.00% 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |